F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risksnews2023-05-10T17:21:21+00:00May 10th, 2023|The New York Times|
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pillnews2023-05-10T12:33:32+00:00May 10th, 2023|The New York Times|
FDA Approves Biogen’s Drug for Rare Form of ALSnews2023-04-25T17:53:59+00:00April 25th, 2023|The New York Times|
Supreme Court Ensures, for Now, Broad Access to Abortion Pillnews2023-04-22T14:39:23+00:00April 22nd, 2023|The New York Times|
Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Marketnews2023-04-19T20:30:08+00:00April 19th, 2023|The New York Times|
Appeals Court Says Abortion Pill Can Remain Available but Imposes Temporary Restrictionsnews2023-04-13T14:42:18+00:00April 13th, 2023|The New York Times|
After Texas Ruling, Democratic States Move to Stockpile Abortion Pillsnews2023-04-12T14:11:19+00:00April 12th, 2023|The New York Times|
Abortion Pill Ruling: Read Annotated Excerpts From F.D.A. Casenews2023-04-12T02:32:14+00:00April 12th, 2023|The New York Times|
Pfizer CEO and Other Drug Company Leaders Condemn Texas Abortion Pill Rulingnews2023-04-11T11:21:49+00:00April 11th, 2023|The New York Times|
